Latin Pharma B2B

Latin Pharma B2B - Strategic Pharmaceutical Networking Platform

What is Latin Pharma B2B?

Latin Pharma B2B is Latin America's most strategic pharmaceutical networking platform. Powered by APROCIF, it has been created so that connections between companies transform into real business decisions, expansion and innovation.

This exclusive model connects laboratories and companies in the pharmaceutical and health sector from Latin America with leading companies from Europe, Asia, the United States and the rest of the continent, creating an ideal environment for the exchange of licenses, technologies, products, services and new commercial opportunities.

🎥 INSTITUTIONAL VIDEO

Discover more about our platform

What makes it different?

Latin Pharma B2B is not a fair, nor a traditional exhibition. It is a carefully designed space for true decision makers —general directors, business development leaders, alliance, licensing and expansion managers— to meet face-to-face or virtually to build strategic alliances.

                  "At Latin Pharma B2B, you don't walk through aisles or visit booths. You sit at a negotiation table with
  those who can grow your business."
              

Two formats, one value network

1. Latin Pharma B2B – In-person meeting

Latin Pharma B2B takes place twice a year in different Latin American capitals, and is recognized as the most effective in-person meeting to drive alliances and strategic decisions within the pharmaceutical sector.

Its structure is based on pre-scheduled 1-to-1 business rounds, where each participating company receives a personalized agenda and meets exclusively with potential partners aligned to their commercial interests.

Direct Meetings

Meet directly with decision makers from regional and global companies

Business Opportunities

Negotiate licensing opportunities, representation, mergers or acquisitions

Strategic Alliances

Explore alliances in research, manufacturing, distribution, APIs, regulatory and clinical studies

Positioning

Position your company within the most dynamic business circuit of the Latin American pharmaceutical industry

Exclusive benefits:

Guaranteed participation in high-value 1-to-1 in-person meetings
Prior listing of participating companies, to prepare your connection strategy
Automatic inclusion in the Pharma B2B Connect digital directory
Active membership in APROCIF, linking you to the regional network of the sector
Assistance from the coordination team, to help you close key appointments during the event
Access to informal networking activities, such as executive cocktails and special sessions

2. Pharma B2B Connect – Digital platform (from October 2025)

It is the digital platform that complements the in-person model of Latin Pharma B2B, designed to extend and strengthen your commercial relationships throughout the year.

Designed so that opportunities initiated at in-person meetings don't stop, this tool will allow you to search, filter, contact and meet virtually with key companies from the Latin American and global pharmaceutical ecosystem.

Interactive Directory

Access to companies from Latin America and the rest of the world, with real interest in the regional market

Validated Profiles

Key information segmented by country, category, company type, commercial interest and operational capabilities

Connection Tools

Request virtual meetings, share business proposals, follow up on key contacts

Exclusive Content

Invitations to strategic content, thematic calls and online networking activities

What is Pharma B2B Connect for?

Initiate relationships before and after participating in an in-person event
Provide strategic follow-up to connections made in 1-to-1 in-person rounds
Explore new alliances at key moments of the year, without waiting for the next edition
Stay present on the radar of those who decide and execute commercial alliances in the regional pharmaceutical sector

                  "Pharma B2B Connect is not a static directory. It is a living network of opportunities, built for
  companies that want to stay connected all year round."
              

Previous Events

1st Edition - Bogotá, Colombia

February 26-27, 2025 Hotel Marriott Bogotá

This first event was consolidated as an effective and high-level space for business development in the pharmaceutical industry, with a Latin American vision.

754 Business meetings

40 Participating companies

70 Senior executives

18 Countries represented

Latin America:

Argentina, Bolivia, Brazil, Colombia, Ecuador, El Salvador, Guatemala, Mexico and Peru

Global companies:

Canada, United States, Italy, Greece, Netherlands, Poland, Portugal, India and South Africa

Upcoming Events

2nd Edition - Bogotá, Colombia

October 8-9, 2025 Hotel Marriott Bogotá

Following the success of the first edition in February, Latin Pharma B2B returns to Bogotá to celebrate its second edition, reaffirming its positioning as the most effective and specialized business meeting in the pharmaceutical sector in the region.

Why Colombia?

Colombia is the fourth largest pharmaceutical market in Latin America, with more than 380 laboratories, distributors and specialized companies. Bogotá concentrates more than 60% of the country's pharmaceutical activity and positions itself as a strategic hub to connect with the Andean region, Central America and the Caribbean.

Official launch of Pharma B2B Connect during this event.

3rd Edition - Buenos Aires, Argentina

April 15-16, 2026 Buenos Aires, Argentina

As part of APROCIF's vision to strengthen the integration and dynamization of the most relevant pharmaceutical markets in Latin America, Latin Pharma B2B arrives in Buenos Aires to celebrate its third edition.

Why Argentina?

Argentina has a robust pharmaceutical industry, with more than 200 laboratories and biotechnology companies, and a strong local production capacity. Buenos Aires concentrates most of these players, offering an ideal base for generating alliances, licensing and regional expansion.

Concrete opportunities:

License differentiated and value-added products to local laboratories
Start or expand operations in the Southern Cone
Connect with companies with a track record in clinical innovation, biosimilars, quality generics and medical devices